INS and obesity disorder: DPP‐4, the enzyme that converts PYY1‐36 to PYY3‐36, is thought to be a mediator of the link between obesity and diabetes by inactivating incretins such as GLP‐1, and regulating inflammation and insulin resistance in the liver and adipose tissue.23